Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Implementatie PrEP: “Onacceptabel dat er nu nog mensen buiten de boot vallen”
feb 2020 | HIV